Edition:
United States

argenx NV (ARGX.OQ)

ARGX.OQ on NASDAQ Stock Exchange Global Select Market

89.16USD
4:00pm EDT
Change (% chg)

$1.09 (+1.24%)
Prev Close
$88.07
Open
$88.19
Day's High
$90.00
Day's Low
$87.54
Volume
14,875
Avg. Vol
63,087
52-wk High
$90.00
52-wk Low
$17.42

Select another date:

Thu, Apr 12 2018

BRIEF-Argenx To Receive Third Preclinical Milestone Payment From Collaboration With Leo Pharma

* TO RECEIVE THIRD PRECLINICAL MILESTONE PAYMENT FROM COLLABORATION WITH LEO PHARMA - MILESTONE ASSOCIATED WITH CTA APPROVAL FOR ARGX

BRIEF-Argenx Appoints Keith Woods As Chief Operating Officer

* ARGENX APPOINTS KEITH WOODS AS CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Argenx Appoints Keith Woods As Chief Operating Officer

* ARGENX APPOINTS KEITH WOODS AS CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Argenx ‍To Present Complete Data From Phase 2 Clinical Trial Of Efgartigimod

* ‍TO PRESENT COMPLETE DATA FROM PHASE 2 CLINICAL TRIAL OF EFGARTIGIMOD (ARGX-113) IN MYASTHENIA GRAVIS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Argenx ‍Announces Orphan Drug Designation For Argx-113 For Treatment Of Myasthenia Gravis In Europe​

* ‍ANNOUNCES ORPHAN DRUG DESIGNATION FOR ARGX-113 FOR TREATMENT OF MYASTHENIA GRAVIS IN EUROPE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Argenx Reports Fourth Quarter Business Update And Full Year 2017 Financial Results

* ARGENX REPORTS FOURTH QUARTER BUSINESS UPDATE AND FULL YEAR 2017 FINANCIAL RESULTS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Argenx FY Total Operating Income Rises To 41.3 Million Euros

* FY REVENUE EUR 36.4‍​ MILLION VERSUS EUR 14.7 MILLION YEAR AGO

BRIEF-Argenx Announces Updated Size Of Proposed Public Offering In The U.S. To 3.5 Million ADSS

* HAS UPDATED NUMBER OF AMERICAN DEPOSITARY SHARES ("ADSS") IN ITS UNDERWRITTEN U.S. PUBLIC OFFERING (OFFERING) TO 3.5 MILLION ADSS

BRIEF-Argenx announces launch of proposed public offering in United States

* ARGENX ANNOUNCES LAUNCH OF PROPOSED PUBLIC OFFERING IN THE UNITED STATES

BRIEF-Argenx Files For Offering Of Up To $150 Mln American Depositary Shares

* ARGENX FILES FOR OFFERING OF UPTO $150.0 MILLION OF AMERICAN DEPOSITARY SHARES - SEC FILING Source text: (http://bit.ly/2kmUxUi) Further company coverage:

Select another date: